News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,422 Results
Type
Article (28405)
Company Profile (72)
Press Release (457945)
Multimedia
Podcasts (90)
Webinars (8)
Section
Business (146912)
Career Advice (1506)
Deals (24117)
Drug Delivery (60)
Drug Development (58054)
Employer Resources (104)
FDA (10925)
Job Trends (10393)
News (242864)
Policy (21372)
Tag
Academia (1795)
Academic (2)
Accelerated approval (7)
Adcomms (15)
Allergies (72)
Alliances (37420)
ALS (85)
Alzheimer's disease (1089)
Antibody-drug conjugate (ADC) (106)
Approvals (10952)
Artificial intelligence (214)
Autoimmune disease (18)
Automation (15)
Bankruptcy (207)
Best Places to Work (8661)
BIOSECURE Act (9)
Biosimilars (71)
Biotechnology (50)
Bladder cancer (70)
Brain cancer (22)
Breast cancer (286)
Cancer (2183)
Cardiovascular disease (175)
Career advice (1282)
Career pathing (25)
CAR-T (115)
CDC (19)
Cell therapy (382)
Cervical cancer (17)
Clinical research (48035)
Collaboration (802)
Compensation (632)
Complete response letters (11)
COVID-19 (1782)
CRISPR (46)
C-suite (200)
Cystic fibrosis (81)
Data (2380)
Decentralized trials (2)
Denatured (27)
Depression (38)
Diabetes (286)
Diagnostics (4498)
Digital health (15)
Diversity (3)
Diversity, equity & inclusion (30)
Drug discovery (93)
Drug pricing (71)
Drug shortages (19)
Duchenne muscular dystrophy (103)
Earnings (69629)
Editorial (37)
Employer branding (13)
Employer resources (92)
Events (86580)
Executive appointments (578)
FDA (12113)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (648)
Gene editing (101)
Generative AI (19)
Gene therapy (307)
GLP-1 (595)
Government (2945)
Grass and pollen (4)
Guidances (157)
Healthcare (13623)
Huntington's disease (19)
IgA nephropathy (30)
Immunology and inflammation (110)
Immuno-oncology (5)
Indications (31)
Infectious disease (1884)
Inflammatory bowel disease (121)
Inflation Reduction Act (9)
Influenza (37)
Intellectual property (84)
Interviews (276)
IPO (12753)
IRA (31)
Job creations (2131)
Job search strategy (1065)
Kidney cancer (8)
Labor market (27)
Layoffs (283)
Leadership (19)
Legal (5120)
Liver cancer (55)
Lung cancer (321)
Lymphoma (161)
Machine learning (3)
Management (37)
Manufacturing (275)
MASH (69)
Medical device (8921)
Medtech (8925)
Mergers & acquisitions (11948)
Metabolic disorders (638)
Multiple sclerosis (75)
NASH (16)
Neurodegenerative disease (78)
Neuropsychiatric disorders (20)
Neuroscience (1571)
NextGen: Class of 2025 (4410)
Non-profit (3459)
Now hiring (14)
Obesity (294)
Opinion (177)
Ovarian cancer (68)
Pain (74)
Pancreatic cancer (87)
Parkinson's disease (135)
Partnered (12)
Patents (203)
Patient recruitment (96)
Peanut (33)
People (35401)
Pharmaceutical (16)
Pharmacy benefit managers (9)
Phase I (13974)
Phase II (20856)
Phase III (16949)
Pipeline (1366)
Policy (127)
Postmarket research (2108)
Preclinical (6247)
Press Release (41)
Prostate cancer (119)
Psychedelics (23)
Radiopharmaceuticals (188)
Rare diseases (345)
Real estate (3455)
Recruiting (40)
Regulatory (15001)
Reports (26)
Research institute (1641)
Resumes & cover letters (230)
Rett syndrome (7)
RNA editing (5)
RSV (33)
Schizophrenia (63)
Series A (102)
Series B (58)
Service/supplier (7)
Sickle cell disease (49)
Special edition (12)
Spinal muscular atrophy (91)
Sponsored (21)
Startups (2081)
State (1)
Stomach cancer (9)
Supply chain (38)
Tariffs (35)
The Weekly (62)
Vaccines (516)
Venture capital (34)
Weight loss (174)
Women's health (26)
Worklife (13)
Date
Last 7 days (475)
Last 30 days (1684)
Last 365 days (24327)
2025 (12661)
2024 (26624)
2023 (29801)
2022 (37313)
2021 (40119)
2020 (38560)
2019 (33095)
2018 (24471)
2017 (22822)
2016 (22214)
2015 (26181)
2014 (21424)
2013 (18214)
2012 (18602)
2011 (18463)
2010 (17411)
Location
Africa (601)
Alabama (49)
Alaska (4)
Arizona (133)
Arkansas (8)
Asia (26542)
Australia (4517)
California (5632)
Canada (1703)
China (485)
Colorado (251)
Connecticut (267)
Delaware (146)
Europe (64780)
Florida (888)
Georgia (184)
Idaho (28)
Illinois (454)
India (22)
Indiana (286)
Iowa (7)
Japan (170)
Kansas (78)
Kentucky (22)
Louisiana (6)
Maine (41)
Maryland (752)
Massachusetts (4308)
Michigan (167)
Minnesota (286)
Missouri (68)
Montana (12)
Nebraska (13)
Nevada (55)
New Hampshire (34)
New Jersey (1668)
New Mexico (13)
New York (1556)
North Carolina (1113)
North Dakota (7)
Northern California (2550)
Ohio (178)
Oklahoma (12)
Oregon (22)
Pennsylvania (1209)
Puerto Rico (5)
Rhode Island (24)
South America (862)
South Carolina (31)
Southern California (2114)
Tennessee (91)
Texas (800)
United States (21110)
Utah (168)
Virginia (118)
Washington D.C. (57)
Washington State (507)
West Virginia (3)
Wisconsin (52)
486,422 Results for "hyman phelps and mcnamara p c".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D., M.S. and Ruchir P. Patel, M.D., F.A.C.P. as Vice President, Senior Medical Directors
April 21, 2025
·
4 min read
Press Releases
IND Application for NTS071, Nutshell Therapeutics’ p53 Y220C Allosteric Reactivator, Received US FDA clearance
May 5, 2025
·
3 min read
Press Releases
Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025
April 29, 2025
·
4 min read
Press Releases
C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
April 28, 2025
·
7 min read
Business
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced the appointment of Steven E. Hyman, M.D., to its Board of Directors effective July 25.
July 26, 2022
·
4 min read
Press Releases
Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series
June 24, 2025
·
3 min read
Press Releases
Whitehawk Therapeutics to Participate in H.C. Wainwright “HCW@Home” Series
June 19, 2025
·
1 min read
Press Releases
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
May 20, 2025
·
3 min read
Genetown
Breakthrough Prize in Life Sciences awarded to Anthony Hyman, Ph.D., pioneer of biomolecular condensates and co-founder of Dewpoint Therapeutics
Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony (Tony) Hyman was awarded the 2023 Breakthrough Prize in Life Sciences for discovering a new mechanism of cellular organization mediated by phase separation of proteins and RNA into membraneless liquid droplets called condensates.
September 22, 2022
·
5 min read
1 of 48,643
Next
